DaVita Inc.

Healthcare

NYSE:DVA · New York Stock Exchange

Market Cap $13.40B Beta 0.91 P/E (TTM) 18.0

$208.66 +2.37%

+$4.83 today

52W Low $101.00High $211.80

Vol 0.74M · Avg 0.85M

EPS (TTM)$11.60

Medical - Care Facilities

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+53.29%

Period High

$208.66

Period Low

$103.87

Latest

$208.66

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Revolution Medicines, Inc.

NASDAQ:RVMD

$32.71B

Align Technology, Inc.

NASDAQ:ALGN

$12.52B

BioMarin Pharmaceutical Inc.

NASDAQ:BMRN

$10.81B

Molina Healthcare, Inc.

NYSE:MOH

$10.43B

Henry Schein, Inc.

NASDAQ:HSIC

$9.26B

Universal Health Services, Inc.

NYSE:UHS

$9.17B

The Ensign Group, Inc.

NASDAQ:ENSG

$8.73B

Bio-Rad Laboratories, Inc.

NYSE:BIO

$7.73B

AptarGroup, Inc.

NYSE:ATR

$7.51B

Chemed Corporation

NYSE:CHE

$5.57B

What is the latest DVA filing?

The latest filing shown is 8-K dated Jun 8, 2026.

How many recent filings does DVA have?

Intrinsic Alpha currently shows 20 recent filings for DVA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.